novavax news - Search News

Novavax cuts 2024 revenue forecast

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell?

Reuters on MSN · 4d

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to Sanofi. The U.S. vaccine maker now expects between $175 million and $225 million for full-year sales of its COVID vaccine,

GlobalData on MSN · 3d

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.

The Business Journals · 3d

Novavax sees weak Covid vaccine sales, convinced Sanofi can do better

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals and a pipeline of new vaccines it's now evaluating for R&D.

Moderna, Lily, Novavax, and Pfizer stocks fall

Fast Company · 23h

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary

Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's pick for HHS.

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.

U.S. News & World Report · 1d

Trump Nominates RFK Jr. to Top U.S. Health Job

Kennedy Jr. attends a campaign event for Republican presidential nominee and former U.S. President Donald Trump in Milwaukee, Wisconsin, U.S. November 1, 2024. REUTERS/Joel Angel Juarez/File Photo LONDON (Reuters) - President-elect Donald Trump said on Thursday he has selected Robert F.

15h

Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains

Shares of Novavax Inc. NVAX rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the ...

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals

Novavax's (NVAX) stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for ...

FDA lifts clinical hold on Novavax's combo COVID-flu shot

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...

2d

Novavax price target lowered to $12 from $14 at BofA

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

10d

Novavax, UK terminate vaccine supply agreement

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

8h

HC Wainwright Estimates Novavax’s Q3 Earnings (NASDAQ:NVAX)

Stock analysts at HC Wainwright issued their Q3 2024 earnings estimates for shares of Novavax in a note issued to investors ...

2d

Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook

Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...

23h

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results